Callisia N. Clarke, MD, MS, FACS, FSSO

Associate Professor and Chief

Request an Appointment

Location

Cancer Center - Froedtert Hospital
8800 West Doyne Ave.
Milwaukee, WI 53226

Specialties

Surgical Oncology

Established Patient Appointments

(414) 955-1434

New Patient Appointments

(414) 805-6849

Overview

Diseases and Conditions

Melanoma
Neuroendocrine Tumors
Pancreatic Cancer
Sarcoma
Benign Pancreatic Disease

Treatments and Services

Limb and Liver Perfusion
Virtual Visit
Primary and Metastatic Neuroendocrine Tumors

Patients Ages Seen

Adult
Senior

Languages

English

Hospital Affiliations

Froedtert Hospital – Milwaukee
Children's Wisconsin - Milwaukee – Milwaukee

Board Certifications

Surgery
Complex General Surgical Oncology

Clinic Locations

Cancer Center - Froedtert Hospital

8800 West Doyne Ave.
Milwaukee, WI 53226
(866) 680-0505
Get Directions

Biography

Dr. Clarke specializes in Surgical Oncology with a focus on tumors of the upper gastrointestinal tract, sarcomas, melanomas and regional therapies for advanced malignancies.

Her research interests are centered on personalized cancer care and targeted approaches in Pancreatic Neuroendocrine Tumors.

Education and Training

Doctor of Medicine - University of Cincinnati College of Medicine - Cincinnati, OH (2006)
General Surgery Residency - University of Cincinnati - Cincinnati, OH (2013)
Complex General Surgical Oncology Fellowship - University of Texas M. D. Anderson Cancer Center - Houston, TX (2016)

Assessing the Complex General Surgical Oncology Pipeline: Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees.

(Collins RA, Sheriff SA, Yoon C, Cobb AN, Kothari AN, Newman LA, Dossett LA, Willis AI, Wong SL, Clarke CN.) Ann Surg Oncol. 2023 Aug;30(8):4579-4586 PMID: 37079205 SCOPUS ID: 2-s2.0-85153059305 04/20/2023
Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.

(Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN.) J Surg Res. 2023 Aug;288:269-274 PMID: 37037166 SCOPUS ID: 2-s2.0-85151667989 04/11/2023
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

(Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S.) J Surg Oncol. 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023
ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

(Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3022 PMID: 36877324 SCOPUS ID: 2-s2.0-85152164746 03/07/2023
Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.

(Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal H.) J Surg Oncol. 2023 Mar;127(4):550-559 PMID: 36477427 SCOPUS ID: 2-s2.0-85147711222 12/09/2022
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.

(Kubi B, Nudotor R, Fackche N, Rowe J, Cloyd JM, Ahmed A, Grotz TE, Fournier K, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB.) J Surg Oncol. 2023 Mar;127(4):706-715 PMID: 36468401 SCOPUS ID: 2-s2.0-85143899672 12/06/2022
Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?

(Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN.) J Surg Res. 2022 Oct;278:31-38 PMID: 35588572 SCOPUS ID: 2-s2.0-85130316020 05/20/2022
Comparison of COVID-19 Rates Among In-Person and Virtual Attendees of a National Surgical Society Meeting in the US.

(Silver CM, Joung RH, Morris MS, Wang KS, Ghaferi AA, Bilimoria KY, Clarke CN.) JAMA Netw Open. 2022 Sep 01;5(9):e2230300 PMID: 36069986 PMCID: PMC9453540 SCOPUS ID: 2-s2.0-85137745353 09/08/2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?

(Beal EW, Chen JC, Kim A, Johnston FM, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Clarke C, Staley C, Patel SH, Lambert L, Cloyd JM.) J Surg Res. 2022 Sep;277:269-278 PMID: 35525209 SCOPUS ID: 2-s2.0-85129473994 05/08/2022
More than a moment: Why surgical societies must continuously strive for diversification and creating a culture of equity and inclusivity in academic surgery.

(Clarke CN.) Am J Surg. 2022 Jul;224(1 Pt B):292-293 PMID: 35337646 PMCID: PMC9745945 SCOPUS ID: 2-s2.0-85127538368 03/27/2022
Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery.

(Deng H, Eftekhari Z, Carlin C, Veerapong J, Fournier KF, Johnston FM, Dineen SP, Powers BD, Hendrix R, Lambert LA, Abbott DE, Vande Walle K, Grotz TE, Patel SH, Clarke CN, Staley CA, Abdel-Misih S, Cloyd JM, Lee B, Fong Y, Raoof M.) JAMA Netw Open. 2022 May 02;5(5):e2212930 PMID: 35612856 PMCID: PMC9133947 SCOPUS ID: 2-s2.0-85131107269 05/26/2022
Surgical Societies Must Lead the Way on Addressing Bias and Microaggressions

(Clarke CN.) Annals of Surgical Oncology. February 2022;29(2):755-757 SCOPUS ID: 2-s2.0-85118456515 02/01/2022